LPCN
Lipocine Inc
NASDAQ: LPCN · HEALTHCARE · BIOTECHNOLOGY
$2.33
+0.00% today
Updated 2026-05-01
Market cap
$19.02M
P/E ratio
—
P/S ratio
9.62x
EPS (TTM)
$-1.77
Dividend yield
—
52W range
$2 – $12
Volume
0.5M
Lipocine Inc (LPCN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-7295.00 | $-62866.00 | $-8.59M | $-17.30M | $-15.36M | $-18.28M | $-16.70M | $-12.08M | $-11.67M | $-15.30M | $-4.41M | $-11.97M | $-11.87M | $-1.22M | $-9.76M |
| Capital expenditures | $20000.00 | $12316.00 | $1206.00 | $59608.00 | $28689.00 | $59650.00 | $0.00 | $7591.00 | $7591.00 | $7591.00 | $7591.00 | $133831.00 | $13167.00 | $90086.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $127487.00 | $979151.00 | $1.89M | $1.15M | $2.37M | $2.72M | $1.46M | $1.04M | $1.37M | $603946.00 | $636140.00 | $654438.00 | $408551.00 | $242497.00 |
| Free cash flow | $-27295.00 | $-75182.00 | $-8.59M | $-17.36M | $-15.38M | $-18.34M | $-16.70M | $-12.09M | $-11.67M | $-15.31M | $-4.42M | $-12.10M | $-11.88M | $-1.31M | $-9.76M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | $211423.00 | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | $-22366.00 | $39.89M | $-17.60M | $-7.66M | $-14.45M | $-2.35M | $9.87M | $1.65M | $9.49M | $-21.27M | — | — | — | — |